Automated Breast Ultrasound Systems (ABUS) Market Size, Share, Growth, and Industry Analysis, By Type (Automated Breast Ultrasound Systems (ABUS), Automated Breast Volume Scanner (ABVS) and Others), By Application (Hospitals and Diagnostic Imaging Centers) and Regional Forecast to 2032

Updated On: 02 September 2024

• 

  Request a Free Sample to learn more about this report

AUTOMATED BREAST ULTRASOUND SYSTEM(ABUS) MARKET REPORT OVERVIEW

The Global Automated Breast Ultrasound Systems (ABUS) Market size was USD 575.52 million in 2023 and the market is projected to touch USD 2610.54 million by 2032, exhibiting a CAGR of 16.32% during the forecast period.

ABUS is a valuable tool in the screening of the breast with improved lesion detection. Conventional transportable ultrasonic diagnostic apparatus is transferred to the often dubbed Operated By Computer or ABUS in which the scanning is done by a computer program.

COVID-19 Impact: Market Growth restrained by the Pandemic due to Advancements in Telehealth and Remote Imaging

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The details of tele consultation and remote imaging activity some of which are shown below have confirmed that there is a high uptake during outbreak of pandemic. ABUS systems and, in particular, the option of obtaining high-resolution images of the breast made these systems useful in situations when radiologists had to examine and discuss patients’ conditions without actually seeing them in person.

LATEST TRENDS

"Expansion in Clinical Applications to Propel Market Growth"

Across clinical uses, there is evidence of current and sustained developments in the ABUS market motivated by ongoing technology enhancements and expanding understanding of the technique’s diagnostic potential. Long incorporated primarily as a supplementary examination to mammography, ABUS is in the process of broadening the scope of its applications in the field of breast imaging. An area of growth is screening women with dense breast tissue, in which mammography could be less efficient because of overlapping tissue characteristics. Whereas, ABUS offers the better contrast for the breast tissue and improves the identification of cancer especially in the early stage due to better transmittance of the technology into the breast tissue.

• 

  Request a Free Sample to learn more about this report

AUTOMATED BREAST ULTRASOUND SYSTEM(ABUS)  MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Automated Breast Ultrasound Systems(ABUS), Automated Breast Volume Scanner (ABVS) and Others.

• "Automated Breast Ultrasound Systems (ABUS)-" ABUS means Automated Breast Ultrasound Systems and the aforementioned can be defined as the equipment used solely for the complete automatically examination of the breast. Several of these systems employ a transducer that includes a mechanical that literally scans across the breast to get several angles of the area of concern.
• "Automated Breast Volume Scanner (ABVS)-" A back-space is more expanded equipment type, one among them is ABVS which is used to collect details regarding the volume on the Breast. The ABVS systems apply an ultrasound transducer that encircles the breast to acquire multiple tomographic planes.

By Application

Based on application the market can be categorized into Hospitals and Diagnostic Imaging Centers.

• "Hospitals"- ABUS thus works in synergy with mammography especially to the dense breasted women where mammography may not be very effective. More than this it gives ancillary imaging to enhance the visualization of small cancers in the early stage that may not be evident in mammography films.
• "Diagnostic Imaging Centers-" Diagnostic imaging centers engage in multiple forms of imaging services for the breast, including ABUS alongside mammography, ultrasound, and others. This system approach enhances comprehensive examination and description of the breast irregularities.

DRIVING FACTORS

"Increasing Awareness and Screening Programs to Drive Market Advancement"

One of the key driving factors in the Automated Breast Ultrasound Systems (ABUS) market growth is Increasing Awareness and Screening Programs. There are two major factors deemed to boost ABUS market; namely the rising level of awareness and the screening programs related to the disease. Social mobilization crusades and health promotion have increased women’s knowledge about early detection of breast cancer thus more women go for breast examinations. These efforts highlight the shortcomings of mammography, particularly on the women with the high density in their breasts because tiny tumors often go unnoticed by mammography.

"Growing Prevalence of Dense Breast Tissue to Expand the Market"

The high incidence of dense breast tissue has been found to be the primary influence of the growth of the ABUS market. High density of breast tissue, as it is present in a large number of women, creates a problem for conventional mammography, since tumors are hidden by dense stroma and the effectiveness of mammographic examination is considerably decreased. Dense tissue shows up as white upon conducting a mammogram, as may the cancers, creating unreliable conclusive results. This limitation poses the need to use other imaging techniques that would enhance the ability to diagnose breast cancer.

RESTRAINING FACTOR

"High Costs and  Technical Challenges Poses Potential Impediments to Market Growth"

Expenses and technical difficulties greatly limit the development of the automated breast ultrasound system (ABUS) and its implementation in clinical practice. The cost of ABUS systems at the onset is high due to the large sum that goes towards the purchase of the sophisticated systems, installation, and the adaptation of structures. These costs are especially concerning to small healthcare facilities and clinics, ones with a few branches and less capital to seize. However, maintenance expense, and other general expenditures for example; expendable goods and staff involved in the operational of the ABUS systems and analysis of the results are some additional costs.

• 

  Request a Free Sample to learn more about this report

AUTOMATED BREAST ULTRASOUND SYSTEM(ABUS) MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America to Dominate the Market due to Advanced Healthcare Infrastructure"

North America has emerged as the most dominant region in the Automated Breast Ultrasound Systems (ABUS) market share due to a convergence of factors that propel its leadership in this dynamic industry. North America, especially the United States is privileged to have well-developed and advanced systems of health care. Both the private and public hospitals and diagnostic centers have modern facilities and equipment including the ABUS system. The region is a powerhouse for medical research and enhancing the medical imaging technologies with strong investment.

KEY INDUSTRY PLAYERS

"Key Players Transforming the Automated Breast Ultrasound Systems (ABUS) Landscape through Innovation and Global Strategy"

Major industry players are pivotal in shaping the Automated Breast Ultrasound Systems (ABUS) market, driving change through a dual strategy of continuous innovation and a well-thought-out global presence. By consistently introducing inventive solutions and staying at the forefront of technological progress, these key players redefine the industry's standards. Simultaneously, their expansive global reach enables effective market penetration, addressing diverse needs across borders. The seamless blend of groundbreaking innovation and a strategic international footprint positions these players as not only market leaders but also as architects of transformative shifts within the dynamic domain of Automated Breast Ultrasound Systems (ABUS).

"List of Market Players Profiled"

• SuperSonic Imagine (France)
• Toshiba Company (Japan)
• Theraclion (France)
• GE Healthcare (U.S.)
• CapeRay (South Africa)

INDUSTRIAL DEVELOPMENT

"Feb 2024"":" Then Butterfly Network developed the iQ™ portable ultrasound system and this includes ImagePure™ 3 that consists of processing, AI and 3D.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.